Related Experiment Video
Updated: Jul 12, 2025

Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV
Teressa S Thomas1, Allie R Walpert, Suman Srinivasa
1Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Insights
Coronary microvascular dysfunction (CMD) is common in people with HIV (PWH), increasing heart failure risk. This condition affects PWH even with well-managed HIV and may be worse in women.
Area of Science:
- Cardiology
- Infectious Diseases
- Vascular Biology
Background:
- Heart failure risk is elevated in people with HIV (PWH).
- Early research focused on large vessel disease in HIV, but recent studies highlight small vessel disease, or coronary microvascular dysfunction (CMD).
- CMD is a significant risk factor for heart failure and cardiovascular mortality, often occurring without significant atherosclerotic disease.
Approach:
- This review synthesizes current understanding of CMD in the context of HIV.
- It examines the role of inflammation and endothelial dysfunction in CMD pathogenesis.
- Clinical studies and implications for PWH are discussed.
Key Points:
- CMD is increasingly recognized in PWH, contributing to heart failure.
- Inflammation and endothelial dysfunction are potential drivers of CMD in HIV.
- CMD may worsen with antiretroviral therapy (ART) initiation but is also present in well-treated PWH.
- Myocardial flow reserve (MFR), a marker for CMD, is reduced in PWH, similar to individuals with diabetes.
- Women with HIV may experience more severe CMD than men.
Conclusions:
- Alterations in the coronary microvasculature are a key factor in subclinical myocardial dysfunction among PWH.
- CMD warrants further clinical investigation in PWH, particularly those without diagnosed cardiovascular disease.
Purpose Of Review:
Large cohort studies have consistently shown the presence of heart failure is approximately doubled among persons with HIV (PWH). Early studies of cardiovascular disease (CVD) in HIV were primarily focused on atherosclerotic burden, and we now have a greater understanding of large vessel disease in HIV. More recent studies have begun to inform us about small vessel disease, or coronary microvascular dysfunction (CMD), in HIV. CMD is recognized to be an important risk factor for adverse events related to heart failure, associated with cardiovascular mortality, and often presents without overt atherosclerotic disease.
Recent Findings:
In this review, we highlight implications for CMD and relevant clinical studies in HIV. Inflammation and endothelial dysfunction, well known risk factors in HIV, may mediate the pathogenesis of CMD. Initial studies suggest that CMD worsens with ART initiation. Newer studies reveal CMD is present among well treated PWH without known CVD. In addition, myocardial flow reserve (MFR), a marker of CMD, is reduced in HIV similar to diabetes. There also appears to be sex differences, such that CMD is worse among women vs. men with HIV.
Summary:
Alterations in the coronary microvasculature may be an important mediator of subclinical myocardial dysfunction that deserves further clinical attention among PWH without known CVD.
More Related Videos
10:04Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure II: Pathophysiology